<DOC>
	<DOCNO>NCT00027378</DOCNO>
	<brief_summary>This large scale study involve fluoxetine ( Prozac ) versus placebo treatment adolescent alcohol use disorder ( AUD ) major depression ( MDD ) . All individual receive treatment 12 week followup phase last 9 month .</brief_summary>
	<brief_title>Pharmacological Intervention Project ( Fluoxetine )</brief_title>
	<detailed_description>Recently , first large-scale double-blind , placebo-controlled study selective serotonin reuptake inhibitor ( SSRI ) antidepressant depress adolescent complete ( Emslie et al. , 1997 ) That study demonstrate efficacy fluoxetine non-AUD adolescent major depressive disorder ( MDD ) . Our research group recently complete first double-blind , placebo-controlled study fluoxetine adult comorbid MDD alcohol dependence ( Cornelius et al. , 1997 ) . That study demonstrate efficacy fluoxetine decrease depressive symptom alcohol use adult depress alcoholic . Our research group also recently complete pilot study involve open label fluoxetine adolescent comorbid AUD MDD . That pilot study demonstrate within-group efficacy fluoxetine decrease drink depressive symptom population , suggest fluoxetine safe medication population ( Cornelius , et al. , In Press ) . However , date , double-blind , placebo-controlled study selective serotonin re-uptake inhibitor ( SSRI ) medication conduct adolescent comorbid AUD MDD . In proposed study , first large scale prospective double-blind , placebo-controlled study undertaken involve SSRI medication fluoxetine versus placebo treatment adolescent alcohol use disorder major depression ( AUD/MDD ) . The goal study include follow : 1 ) compare efficacy SSRI medication fluoxetine plus Treatment As Usual ( TAU ) placebo plus TAU alcohol use depressive symptom adolescent sample ( age 15 18 ) subject comorbid diagnose AUD MDD ; 2 ) ass specific predictor medication response study ; perform preliminary evaluation longer-term efficacy fluoxetine patient , 9-month naturalistic follow-up period beyond 3 month acute phase study . We hypothesize fluoxetine plus TAU demonstrate efficacy decrease drink depressive symptom population .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Meets criteria alcohol use disorder major depressive disorder . Meets criteria bipolar disorder , schizoaffective disorder , schizophrenia . Hyper hypothyroidism , significant cardiac , neurologic , renal impairment , significant liver disease . Receiving antipsychotic antidepressant medication month prior enter study . Use illicit substance abuse dependence cannabis abuse ( alcohol abuse ) . History intravenous drug use . Pregnancy , inability unwillingness use contraceptive method . Inability read understand study form Less 15 year age 18 year age exclude .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>fluoxetine ,</keyword>
	<keyword>adolescent ,</keyword>
	<keyword>alcohol dependence ,</keyword>
	<keyword>major depression</keyword>
	<keyword>Alcoholism</keyword>
</DOC>